Vanguard Group Inc

13F Holdings History for Elevance Health, Inc. - Common Stock (ELV)

Symbol: ELV on NYSE
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 22.9M shares
Security Ownership: 10.1%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Elevance Health, Inc. Common Stock (ELV)

2025-05-07 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 22.9M shares of Elevance Health, Inc. Common Stock (ELV). This represents 10.1% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	10.13%		$9.97B	22.9M			$435.68	13G/A	4/30/2025	7 May 2025 10:07:38

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.14%	+0%	$8.89B	22.9M	+704,790	+3.18%	$388.96	Q2 2025
3/31/2025	0.17%	+0.01%	$9.64B	22.2M	+666,534		$434.96	Q1 2025
12/31/2024	0.14%	+0%	$7.93B	21.5M	+138,380	+0.65%	$368.90	Q4 2024
9/30/2024	0.2%	+0%	$11.1B	21.3M	+140,269	+0.66%	$520.00	Q3 2024
6/30/2024	0.22%	0%	$11.5B	21.2M	-24,784	-0.12%	$541.86	Q2 2024
3/31/2024	0.22%	+0%	$11B	21.2M	+4,519	+0.02%	$518.54	Q1 2024
12/31/2023	0.22%	+0%	$10B	21.2M	+23,807	+0.11%	$471.56	Q4 2023
9/30/2023	0.23%	0%	$9.23B	21.2M	-131,330	-0.62%	$435.42	Q3 2023
6/30/2023	0.22%	0%	$9.48B	21.3M	-137,867	-0.64%	$444.29	Q2 2023
3/31/2023	0.25%	0%	$9.87B	21.5M	-864	0%	$459.81	Q1 2023
12/31/2022	0.3%	+0%	$11B	21.5M	+239,661	+1.13%	$512.97	Q4 2022
9/30/2022	0.28%	+0%	$9.65B	21.2M	+183,370	+0.87%	$454.24	Q3 2022
6/30/2022	0.29%	+0%	$10.2B	21.1M	+277,518	+1.34%	$482.58	Q2 2022
3/31/2022	0.24%	+0.02%	$10.2B	20.8M	+1,860,427	+9.84%	$491.22	Q1 2022
12/31/2021	0.2%	0%	$8.77B	18.9M	-15,598	-0.08%	$463.54	Q4 2021
9/30/2021	0.18%	+0%	$7.06B	18.9M	+17,645	+0.09%	$372.80	Q3 2021
6/30/2021	0.18%	+0%	$7.22B	18.9M	+65,981	+0.35%	$381.80	Q2 2021
3/31/2021	0.18%	0%	$6.76B	18.8M	-110,134	-0.58%	$358.95	Q1 2021
12/31/2020	0.18%	0%	$6.09B	19M	-375,159	-1.94%	$321.09	Q4 2020
9/30/2020	0.17%	0%	$5.19B	19.3M	-321,519	-1.64%	$268.59	Q3 2020
6/30/2020	0.18%	0%	$5.17B	19.7M	-354,942	-1.77%	$262.98	Q2 2020
3/31/2020	0.19%	+0%	$4.54B	20M	+495,707	+2.54%	$227.04	Q1 2020
12/31/2019	0.2%	0%	$5.89B	19.5M	-4,911	-0.03%	$302.03	Q4 2019
9/30/2019	0.17%	+0%	$4.69B	19.5M	+44,613	+0.23%	$240.10	Q3 2019
6/30/2019	0.21%	+0%	$5.49B	19.5M	+146,654	+0.76%	$282.21	Q2 2019
3/31/2019	0.22%	+0%	$5.55B	19.3M	+196,086	+1.03%	$286.98	Q1 2019
12/31/2018	0.23%	+0%	$5.02B	19.1M	+398,571	+2.13%	$262.63	Q4 2018
9/30/2018	0.2%	+0.01%	$5.13B	18.7M	+532,579	+2.93%	$274.05	Q3 2018
6/30/2018	0.18%	+0%	$4.33B	18.2M	+216,648	+1.2%	$238.03	Q2 2018
3/31/2018	0.17%	+0%	$3.95B	18M	+176,665	+0.99%	$219.70	Q1 2018
12/31/2017	0.18%	0%	$4.01B	17.8M	-174,025	-0.97%	$225.01	Q4 2017
9/30/2017	0.16%	+0%	$3.41B	18M	+172,881	+0.97%	$189.88	Q3 2017
6/30/2017	0.16%	+0%	$3.35B	17.8M	+479,046	+2.76%	$188.13	Q2 2017
3/31/2017	0.15%	+0.01%	$2.87B	17.3M	+700,705	+4.21%	$165.38	Q1 2017
12/31/2016	0.13%	+0%	$2.39B	16.6M	+232,327	+1.42%	$143.77	Q4 2016
9/30/2016	0.12%	+0%	$2.05B	16.4M	+401,294	+2.51%	$125.31	Q3 2016
6/30/2016	0.13%	+0%	$2.1B	16M	+386,213	+2.47%	$131.34	Q2 2016
3/31/2016	0.14%	+0%	$2.17B	15.6M	+491,837	+3.25%	$138.99	Q1 2016
12/31/2015	0.14%	+0%	$2.11B	15.1M	+270,474	+1.82%	$139.44	Q4 2015
9/30/2015	0.15%	+0%	$2.08B	14.8M	+38,454	+0.26%	$140.00	Q3 2015
6/30/2015	0.16%	+0%	$2.43B	14.8M	+58,018	+0.39%	$164.14	Q2 2015
3/31/2015	0.15%	+0%	$2.28B	14.7M	+346,790	+2.41%	$154.41	Q1 2015
12/31/2014	0.13%	+0.13%	$1.81B	14.4M	+14,399,568	NEW	$125.67	Q4 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.